Literature DB >> 18490452

G protein activation by the leukotriene B4 receptor dimer. Evidence for an absence of trans-activation.

Marjorie Damian1, Sophie Mary, Aimée Martin, Jean-Philippe Pin, Jean-Louis Banères.   

Abstract

There is compelling evidence that G protein-coupled receptors exist as homo- and heterodimers, but the way these assemblies function at the molecular level remains unclear. We used here the purified leukotriene B(4) receptor BLT1 stabilized in its dimeric state to analyze how a receptor dimer activates G proteins. For this, we produced heterodimers between the wild-type BLT1 and a BLT1/ALXR chimera. The latter is no longer activated by leukotriene B(4) but is still activated by ALXR agonists. In this heterodimer, agonist binding to either one of the two protomers induced asymmetric conformational changes within the receptor dimer. Of importance, no G protein activation was observed when using a dimer where the ligand-loaded protomer was not able to trigger GDP/GTP exchange due to specific mutations in its third intracellular loop, establishing that the conformation of the agonist-free protomer is not competent for G protein activation. Taken together, these data indicate that although ligand binding to one protomer in the heterodimer is associated with cross-conformational changes, a trans-activation mechanism where the ligand-free subunit would trigger GDP/GTP exchange cannot be considered in this case for G protein activation. This observation sheds light into the way GPCR dimers, in particular heterodimers, could activate their cognate G proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18490452      PMCID: PMC3258929          DOI: 10.1074/jbc.M710419200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Cis- and trans-activation of hormone receptors: the LH receptor.

Authors:  Inhae Ji; ChangWoo Lee; YongSang Song; P Michael Conn; Tae H Ji
Journal:  Mol Endocrinol       Date:  2002-06

2.  Asymmetric functioning of dimeric metabotropic glutamate receptors disclosed by positive allosteric modulators.

Authors:  Cyril Goudet; Julie Kniazeff; Veronika Hlavackova; Fanny Malhaire; Damien Maurel; Francine Acher; Jaroslav Blahos; Laurent Prézeau; Jean-Philippe Pin
Journal:  J Biol Chem       Date:  2005-04-29       Impact factor: 5.157

3.  Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity.

Authors:  Eneko Urizar; Lucia Montanelli; Tiffany Loy; Marco Bonomi; Stéphane Swillens; Céline Gales; Michel Bouvier; Guillaume Smits; Gilbert Vassart; Sabine Costagliola
Journal:  EMBO J       Date:  2005-05-12       Impact factor: 11.598

Review 4.  Principles: a model for the allosteric interactions between ligand binding sites within a dimeric GPCR.

Authors:  Thierry Durroux
Journal:  Trends Pharmacol Sci       Date:  2005-07       Impact factor: 14.819

5.  Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers.

Authors:  Laïla El-Asmar; Jean-Yves Springael; Sébastien Ballet; Eneko Urizar Andrieu; Gilbert Vassart; Marc Parmentier
Journal:  Mol Pharmacol       Date:  2004-10-27       Impact factor: 4.436

Review 6.  Dimerization of chemokine receptors and its functional consequences.

Authors:  Jean-Yves Springael; Eneko Urizar; Marc Parmentier
Journal:  Cytokine Growth Factor Rev       Date:  2005-06-23       Impact factor: 7.638

7.  Co-expression of defective luteinizing hormone receptor fragments partially reconstitutes ligand-induced signal generation.

Authors:  Y Osuga; M Hayashi; M Kudo; M Conti; B Kobilka; A J Hsueh
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

8.  Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR.

Authors:  Veronika Hlavackova; Cyril Goudet; Julie Kniazeff; Alice Zikova; Damien Maurel; Claire Vol; Johana Trojanova; Laurent Prézeau; Jean-Philippe Pin; Jaroslav Blahos
Journal:  EMBO J       Date:  2005-01-20       Impact factor: 11.598

9.  Cooperative conformational changes in a G-protein-coupled receptor dimer, the leukotriene B(4) receptor BLT1.

Authors:  Danielle Mesnier; Jean-Louis Banères
Journal:  J Biol Chem       Date:  2004-09-09       Impact factor: 5.157

10.  Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers.

Authors:  Jean-Yves Springael; Phu Nguyen Le Minh; Eneko Urizar; Sabine Costagliola; Gilbert Vassart; Marc Parmentier
Journal:  Mol Pharmacol       Date:  2006-02-07       Impact factor: 4.436

View more
  20 in total

1.  Revisiting and questioning functional rescue between dimerized LH receptor mutants.

Authors:  Meilin Zhang; Rongbin Guan; Deborah L Segaloff
Journal:  Mol Endocrinol       Date:  2012-03-08

2.  Trans-activation between 7TM domains: implication in heterodimeric GABAB receptor activation.

Authors:  Carine Monnier; Haijun Tu; Emmanuel Bourrier; Claire Vol; Laurent Lamarque; Eric Trinquet; Jean-Philippe Pin; Philippe Rondard
Journal:  EMBO J       Date:  2010-11-09       Impact factor: 11.598

Review 3.  Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes.

Authors:  Nicola J Smith; Graeme Milligan
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

4.  Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia.

Authors:  José L Moreno; Patricia Miranda-Azpiazu; Aintzane García-Bea; Jason Younkin; Meng Cui; Alexey Kozlenkov; Ariel Ben-Ezra; Georgios Voloudakis; Amanda K Fakira; Lia Baki; Yongchao Ge; Anastasios Georgakopoulos; José A Morón; Graeme Milligan; Juan F López-Giménez; Nikolaos K Robakis; Diomedes E Logothetis; J Javier Meana; Javier González-Maeso
Journal:  Sci Signal       Date:  2016-01-12       Impact factor: 8.192

5.  Heterodimerization with Its splice variant blocks the ghrelin receptor 1a in a non-signaling conformation: a study with a purified heterodimer assembled into lipid discs.

Authors:  Sophie Mary; Jean-Alain Fehrentz; Marjorie Damian; Gérald Gaibelet; Hélène Orcel; Pascal Verdié; Bernard Mouillac; Jean Martinez; Jacky Marie; Jean-Louis Banères
Journal:  J Biol Chem       Date:  2013-07-09       Impact factor: 5.157

6.  G protein activation by serotonin type 4 receptor dimers: evidence that turning on two protomers is more efficient.

Authors:  Lucie P Pellissier; Gaël Barthet; Florence Gaven; Elisabeth Cassier; Eric Trinquet; Jean-Philippe Pin; Philippe Marin; Aline Dumuis; Joël Bockaert; Jean-Louis Banères; Sylvie Claeysen
Journal:  J Biol Chem       Date:  2011-01-19       Impact factor: 5.157

Review 7.  Novel anti-inflammatory--pro-resolving mediators and their receptors.

Authors:  Charles N Serhan; Sriram Krishnamoorthy; Antonio Recchiuti; Nan Chiang
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

Review 8.  Leukotrienes in atherosclerosis: new target insights and future therapy perspectives.

Authors:  Graziano Riccioni; Alessandra Zanasi; Nicola Vitulano; Barbara Mancini; Nicolantonio D'Orazio
Journal:  Mediators Inflamm       Date:  2010-01-26       Impact factor: 4.711

Review 9.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

10.  Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation.

Authors:  Yang Han; Irina S Moreira; Eneko Urizar; Harel Weinstein; Jonathan A Javitch
Journal:  Nat Chem Biol       Date:  2009-08-02       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.